These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9881060)

  • 1. New NO donors with antithrombotic and vasodilating activities, part 25. Hydroxylamine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Nov; 331(11):365-7. PubMed ID: 9881060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New NO-donors with antithrombotic and vasodilating activities, XII: Mesoionic oxatriazoles and related noncyclic nitrosohydrazine derivatives.
    Rehse K; König P
    Arch Pharm (Weinheim); 1995 Feb; 328(2):137-42. PubMed ID: 7726739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New NO-donors with antithrombotic and vasodilating activities, VIII: Benzothiazole-2(3H)-nitrosimines.
    Rehse K; Ciborski T; Lüdtke E
    Arch Pharm (Weinheim); 1994 Dec; 327(12):771-7. PubMed ID: 7872854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate.
    Yang XZ; Diao XJ; Yang WH; Li F; He GW; Gong GQ; Xu YG
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2089-92. PubMed ID: 23466230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Nitrosoimino-3,6-dihydro-2H-1,3,4-thiadiazines with antiplatelet and antithrombotic properties.
    Rehse K; Brümmer U; Unsöld E
    Pharmazie; 1998 Dec; 53(12):820-4. PubMed ID: 9879566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiaggregating and antithrombotic activities of new 1, 2, 3-triazolecarboxamides.
    Cwiklicki A; Rehse K
    Arch Pharm (Weinheim); 2004 Mar; 337(3):156-63. PubMed ID: 15038061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New NO-donors with antithrombotic and vasodilating activities, Part 14. 1,3,4-Triazol-1-oles.
    Rehse K; Piechocki D; Schober M; Scheffler H; Reitner N; Unsöld E
    Arch Pharm (Weinheim); 1996 Nov; 329(11):511-3. PubMed ID: 8997901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NO donors with antithrombotic and vasodilating activities, Part 23. Organic azides.
    Satyanarayana K; Rehse K
    Arch Pharm (Weinheim); 1998 Jun; 331(6):207-10. PubMed ID: 9713253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New NO donors with antithrombotic and vasodilating activities, Part 27. Azide oximes and 1-hydroxytetrazoles.
    Rehse K; Brehme F
    Arch Pharm (Weinheim); 2000 Jun; 333(6):157-61. PubMed ID: 10909186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New NO-donors with antithrombotic and vasodilating activities, Part 19. Pseudonitroles and their dimeric azodioxides.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Feb; 331(2):79-84. PubMed ID: 9525092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New NO donors with antithrombotic and vasodilating activities, Part 24. Hydrazine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Oct; 331(10):308-12. PubMed ID: 9844577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New NO-donors with antithrombotic and vasodilating activities, Part 16. 3-Amino-1,2,4-oxadiazol-5-ones as prodrugs for hydroxyguanidines.
    Rehse K; Bade S
    Arch Pharm (Weinheim); 1996 Dec; 329(12):535-40. PubMed ID: 9038421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New NO-donors with antithrombotic and vasodilating activities, part 15 nitrolic acids.
    Rehse K; Herpel M; Piechocki D
    Arch Pharm (Weinheim); 1996 Feb; 329(2):83-6. PubMed ID: 8851471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New NO donors with antithrombotic and vasodilating activities. Part 22. Nitrosation products of hexamethylenetetramine.
    Herpel M; Rehse K
    Arch Pharm (Weinheim); 1999 Jul; 332(7):255-7. PubMed ID: 10450171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
    Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
    J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New NO-donors with antithrombotic and vasodilating activities, Part 17. Arylazoamidoximes and 3-arylazo-1,2,4-oxadiazol-5-ones.
    Rehse K; Bade S; Harsdorf A; Clement B
    Arch Pharm (Weinheim); 1997 Dec; 330(12):392-8. PubMed ID: 9474899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New NO donors with antithrombotic and vasodilating activities, Part 26. Amidoximes and their prodrugs.
    Rehse K; Brehme F
    Arch Pharm (Weinheim); 1998 Dec; 331(12):375-9. PubMed ID: 9923191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of 4,4a,5,6-tetrahydro-7,8-disubstituted-benzo[h]cinnolin-3(2H)-ones.
    Pinna GA; Loriga M; Curzu MM; D'Amico M
    Farmaco; 1997 Jan; 52(1):25-8. PubMed ID: 9181677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of substituted benzo[h]cinnolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and antithrombotic 5H-indeno[1,2-c]pyridazinones.
    Cignarella G; Barlocco D; Pinna GA; Loriga M; Curzu MM; Tofanetti O; Germini M; Cazzulani P; Cavalletti E
    J Med Chem; 1989 Oct; 32(10):2277-82. PubMed ID: 2795599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New NO-donors with antithrombotic and vasodilating activities, IX: Thiadiazole nitrosimines.
    Rehse K; Lüdtke E
    Arch Pharm (Weinheim); 1995 Jan; 328(1):17-20. PubMed ID: 7695468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.